When Tang Xianhu led Tang Lou into the conference room, several representatives of internationally renowned pharmaceutical giants had been waiting for a long time, but no one complained. Instead, they were full of expectations.

After seeing Tang Lou, several people in charge stood up and said hello, especially Alex, who came over very excitedly and gave Tang Lou a hug: "Tang, I am very happy to see you! You are really a genius!

"

Tangxianhu was also a little surprised by the enthusiasm of these big guys.

However, Jin Yu and Kim Yuna also took advantage of the opportunity to sit in. Of course the heads of the other foreign giants knew Jin Yu and were even more curious about Kim Yuna.

After all, there are rumors that Tang Lou and Kim Yuna have an unusual relationship. Seeing Kim Yuna's appearance and figure, these big guys also looked at Tang Lou in tacit understanding, showing an expression that we understand.

"Hey, Dean Tang, no representative from Pfizer Group came to this meeting?"

Under normal circumstances, it would be unbelievable for such a gathering to be without Pfizer. Faced with Zhang Wujun, the head of GlaxoSmithKline, Mr. Zhang asked questions.

Tang Xianhu smiled and said in an indifferent tone: "On Weibo, the person in charge of Pfizer's China region was very unfriendly to Tanglou and repeatedly made provocations. Therefore, I directly refused their exchange visit."

Hearing what Tang Xianhu said, several big guys present were also a little shocked.

Of course Tang Xianhu had his purpose in saying this, which was to tell these pharmaceutical giants directly about the status of Tanglou in Tang Xianhu's eyes and the Zijingang University School of Medicine.

Even Pfizer can't bully Tanglou!

Tanglou himself did not expect that Dean Tang would reject the olive branch of Pfizer, the world's largest pharmaceutical company, for his own sake, and he was slightly moved.

"Thank you very much for coming to Zijingang University School of Medicine today. Tang Xianhu welcomes you on behalf of the school!"

After all, Tang Xianhu is the dean of the Zijingang University School of Medicine and the chief scientist of the National Major Scientific Research Project (973). He has an extraordinary aura and has received many senior executives.

However, in front of the representatives of these pharmaceutical giants, he showed no timidity at all and spoke with great eloquence.

After some exchanges with representatives of these pharmaceutical companies, Hu Kan turned the meeting to key topics.

"Alex, tell me what you think?"

Tang Xianhu looked at Alex, the editor-in-chief of "Cell". Alex nodded slightly, looked at Tanglou, and said the plan he had prepared for a long time: "Dean Tang, to be honest, this time I will

I came here for Dr. Tang. The first purpose is to visit this young scientific research genius in person. The second purpose is to

I was discussing the matter of ICR mice with Dr. Tang. I suggested that Dr. Tang license the patent of the ICR mouse inbred strain in the United States to Johnson & Johnson, which is also my old employer. In return, Johnson & Johnson is willing to conduct in-depth discussions with Zijingang University.

Through cooperation, we provide twenty internship positions for Zijingang University School of Medicine every year.”

Paul, the chairman of Johnson & Johnson Pharmaceuticals, nodded and added: "At the same time, our company is willing to set up a special fund in your hospital to encourage students to conduct scientific research. As for the chairman of the foundation, I hope Dr. Tang will be the chairman.

"

After listening to Paul and Alex's suggestions, even though Tangxian Lake was a little unexpected, this one was already very sincere.

While thinking in Tangxian Lake, Li Zhi, the head of Novartis Group China, also expressed his position:

"We at Novartis are also willing to carry out in-depth cooperation with your institute, establish a special foundation, and provide twenty internship positions for students from your institute. The requirement is to license the European patent for the ICR mouse inbred strain."

"We, GlaxoSmithKline, are willing to double the number of internship positions and set up a special fund to encourage scientific research talents in your institute."

"Sanofi is also willing to provide 40 internship positions and set up a special fund to encourage scientific research talents in your institute."

Several people in charge expressed their opinions in succession, and Tangxian Lake suddenly felt a sense of happiness. Internship positions for such international giant pharmaceutical companies are very scarce even in Zijingang Hospital, let alone special scientific research funds. This is very important for the comprehensive development of the college.

Strength is a very big plus point.

With these special funds, students and tutors of the college will be able to have better conditions to conduct research projects.

Of course, the more important thing is influence. Being favored by so many pharmaceutical giants will greatly improve the reputation of the college.

However, these ultimately depend on Tang Lou’s opinion.

Tang Xianhu looked directly at Tanglou, and the remaining bosses also glanced over.

Tanglou was a little unaccustomed to being stared at by so many big guys, so he coughed lightly: "Actually, it's a great honor to meet with the heads of various companies this time. Regarding the patent license of the ICR mouse inbred strain, like this

, I will exclusively license it to Johnson & Johnson in the United States, and I will license it to the three of you in Europe. As for the subsequent market share, it will be up to you to compete for it."

Johnson & Johnson was certainly very proud to hear such an allocation from Tanglou. The other three companies in Europe, although a little regretful, were better than nothing.

After thinking about it, several people in charge agreed to Tanglou's plan: "So, what are your requirements, Doctor Tang?"

"Before I make the request, I have one more thing to announce, and I will conduct a research project next."

After hearing what Tanglou said, everyone except Alex, Paul and Jin Yujin Yuner were a little confused.

"Doctor Tang, do you have any other scientific research projects?"

"Yes, in addition to the ICR mouse inbred strain, I also completed the synthesis of compound samples of new hypertension drugs during this period, and are about to enter the clinical trial stage. Therefore, I hope to get your help."

After hearing what Tanglou said, the eyes of several people in charge suddenly turned red. New medicine for high blood pressure!

These pharmaceutical giants naturally understand the prospects of new drugs for high blood pressure. There has been no progress in this field for a long time.

On the side of Tangxian Lake, he was also breathing rapidly. It seemed that this Tanglou had hidden such a big thing from him, which seemed to be beyond his control.

However, Tangxian Lake is also very deep, and there is no emotional fluctuation at all. He directly handed over the leadership of the meeting to Tanglou. He also wanted to see what Tanglou meant.

Tanglou directly took out the notebook he had prepared long ago and connected it to the projection in the conference room. He quickly introduced the general situation of felodipine, as well as the preliminary analysis of the finished product and the outlook for the market prospects.

After reading this, the leaders of these pharmaceutical giants went a little crazy.

"Tang, tell me what you think?"

"Yes, Dr. Tang, then how do you plan to conduct clinical trials next?"

"Dr. Tang, as long as you are willing, our company can provide all resources and financial support."

"Dr. Tang, as long as you are willing, you can come to our company as a consultant and our company will meet all your needs."

"Dr. Tang, as long as you come, you can pay whatever you want."

...

Regarding the temptations of various companies, Tang Lou remained sober and said slowly: "My plan is very clear. First of all, I will definitely put the research and development of this drug into the laboratory of Zijingang University. Secondly, after the new drug

After the research and development is completed, I can hand over the regional agency rights to various companies here. And my request is also very simple. Each of your companies will provide 50 OFFERs to Zijingang University School of Medicine graduates every year. Then, each company will pay every year

US$10 million as scientific research fund.”

Tanglou looked at Tang Xianhu again: "Dean Tang, I hope to make this topic of mine a National Natural Science Foundation project. Then, build a key pharmacy major (hypertensive medicine direction) around this topic, and then

Start building a talent echelon and create a distinctive professional discipline in our college."

After Tanglou finished speaking, whether it was a coincidence or pre-rehearsed, Jin Yuner said directly: "Dean Tang, I think if we want to do it, we should simply make it bigger. It's not just about construction disciplines. Our Jin Group is willing to invest in Zijin."

The Faculty of Medicine of the University of Hong Kong has built a new laboratory specifically for researching high blood pressure drugs and cultivating talents in the field of high blood pressure drugs. Moreover, in the future, students who graduate from the laboratory can work in our Jin Group."

After hearing what Jin Yuner said, the other big guys also agreed and simply pooled the funds from various companies together as the fund for this new laboratory.

As long as they can obtain the agency sales rights of felodipine, they can recover all their investment in just one year. Of course, these pharmaceutical giants will be happy to do so.

Moreover, when they invested in this laboratory, in addition to high blood pressure drugs, they valued Tanglou's potential even more.

Spending 10 million US dollars a year to gain the friendship of a tenement house is of course a safe deal.

Tanglou proposed this idea after careful consideration. First, he wanted to repay Tang Xianhu and Professor Liu for their training. He also had a selfish motive, which was to cultivate talents for his company by establishing a new laboratory.

As long as disciplines and laboratories are established, and there is cooperation and exchange between these pharmaceutical giants, a group of outstanding pharmaceutical talents will surely be cultivated.

Jin Yu added on the side: "But Dean Tang, the premise of the investment fund is that Tang Lou must serve as the person in charge of this laboratory, and we also require Tang Lou to serve as the honorary director of the new pharmacy major (hypertension)."

The dean of the department, as well as the chairman of the fund, of course must also be Tang Lou.”

"Second."

"We agree too."

After hearing the statements of these pharmaceutical giants, Tang Xianhu took a deep breath and looked at Tanglou again, as if he was getting to know him all over again.

However, after thinking about it for a moment, he also understood that the prerequisite for all this cooperation was Tang Lou.

Although according to Tang Lou's qualifications, it is a bit too shocking to serve as the person in charge of a new laboratory and the honorary director of a newly established discipline, but a genius like Tang Lou cannot be regarded with common sense.

Of course, the most important thing is that the offers and investment funds from these pharmaceutical companies, as well as the buildings donated by the Kim Group, are too tempting.

For Zijingang Medical College, it is completely beneficial without any harm.

Tang Xianhu took a deep breath: "I agree too. These things will be announced in the lecture report tonight!"

"Everyone, happy cooperation!"
Chapter completed!